Dubai: Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, has held a series of meetings on the sidelines of the World Health Expo (WHX) 2026 taking place at Expo City Dubai. These meetings are part of efforts to promote a shared responsibility between the public and private sectors to strengthen health sustainability and ensure pharmaceutical security.
According to Emirates News Agency, the meetings, attended by Dr. Fatima Al Kaabi, Director General of the Emirates Drug Establishment, brought together a group of leading global pharmaceutical companies. The aim was to enhance cooperation in pharmaceutical innovation and cement strategic partnerships with major international players. The bilateral meetings focused on expanding collaboration in drug innovation, upgrading the national pharmaceutical model, ensuring the sustainability of medical products, and developing the UAE's national pharmaceutical manufacturing capabilities and competitiveness.
The discussions also aimed to stimulate specialized research and product development studies within the UAE, further reinforcing strategic partnerships with leading global companies. During the event, Al Hajeri met with Andrey Terekhin, Trade Representative of the Russian Federation to the UAE, and his delegation. The talks covered the latest developments in health and pharmaceutical cooperation between the UAE and Russia, exploring opportunities to deepen partnerships in scientific research, knowledge transfer, and expertise exchange.
The two sides also discussed innovative healthcare initiatives and future projects to enhance bilateral cooperation and support long-term pharmaceutical security. The minister emphasized that holding a series of meetings with pharmaceutical companies and international partners reaffirms the UAE's commitment to building effective global partnerships that support innovation, localize vital pharmaceutical industries, and enhance health system readiness.
Al Hajeri stated, "The Emirates Drug Establishment is committed to supporting national priorities to develop an advanced, sustainable, and knowledge-driven healthcare sector underpinned by advanced technologies."